Rubicon Research Limited (BOM:544578)
918.45
-11.55 (-1.24%)
At close: Apr 21, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 151.79 billion as of April 21, 2026.
Market Cap
151.79B
Enterprise Value
155.95B
Revenue
15.98B
Ranking
n/a
PE Ratio
73.62
Stock Price
918.45
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 151.79B, an increase of 46.67%. That is a compound annual growth rate of 111.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 151.79B | 35.34% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 212.72B |
| Granules India | 162.16B |
| Rubicon Research | 148.09B |
| Jubilant Pharmova | 144.39B |
| Caplin Point Laboratories | 134.73B |
| CORONA Remedies | 99.05B |
| Viyash Scientific | 91.18B |